Myositis ossificans progressive: case report

Myositis ossificans progressive: case report

Sofia Talbi^1,&, Nassira Aradoini¹, Iman El Mezouar¹, Fatima Ezzahra Abourazzak¹, Taoufik Harzy¹

¹Department of Rheumatology, University Hospital Hassan II, Fes, Morocco

^&Corresponding author
Sofia Talbi, Department of Rheumatology, University Hospital Hassan II, Fes, Morocco

Myositis ossificansprogressiva (MOP) is an autosomal dominant disorder. This disease is very rare with an incidence of less than 1 in 10,000,000 populations. There is a progressive ectopic ossification and skeletal malformation, mainly in the connective tissue of muscle. Muscles most often involved are brachialis, quadriceps femoris and adductor muscles of thigh. The diagnosis is based on the clinical findings and radiological demonstration of the skeletal malformations. Early and correct diagnosis is fundamental for indication of proper management of the disease .We report the case of a 38-year-old woman with clinical and radiological features of MOP.

A 38 -year-old female patient consulted at our department .She has no family or individual medical history. She has presented 3 years earlier, a progressive increase in thigh volume with functional disability. On the physical examination we have found a painless mass of the right thigh with hard consistency and neovascularization (Figure 1). Results of laboratory studies were normal: erythrocyte sedimentation rate (ESR) C-reactive protein (CRP) and calcium and phosphate levels. The radiography of the right thigh showed a large calcifications or ectopic bone of soft tissues (Figure 2). The magnetic resonance imaging (MRI) of the thigh has shown a significant increase of the right thigh muscles witha high signal intensity on T2- weighted images related tocalcification area. A muscle biopsy was done with immunohistological study and the result was in favor of myositis ossificans. Written informed consent was obtained from the patient's legal guardian for publication of the case.

Myositis ossificansprogressiva is a rare hereditary mesodermal disorder, Itis a mutation in chromosome 2 in the bone morphogenetic protein type, receptor ACVRI, with an incidence of less than 1 in 10,000,000 populations affecting all ethnic backgrounds with both sexes equally [1]. More than 95% of cases are sporadic and comes from de novomutation.There is progressive ectopic ossification and characteristics skeletal malformationslike malformations of the big toe .Ectopic bone formation occurs in the connective tissue within the muscles, fascia, tendons, ligaments and joint capsules [2]. In our case the woman does not present the malformation of the big toe. This malformation was reported in 79-100% of patients is considered pathognomonic sign [3]. Early clinical manifestation is characterized by soft tissue ossification, especially of the neck and other areas, such as those of the lower limbs and dorsum can also be affected in early clinical status [4]. The disease is characterized by frequent edemas as a result of inflammatory processes that causes ossification and, subsequently, restriction of motility of the affected regionwhich may become painful. The women in the case discussed had no pain but his movements were apparently restricted. Thediagnosis depends on the clinical and radiological demonstration of the characteristic skeletal malformation. Routine laboratory testsare usually normal or noncontributive [5]. Moreover, the severity of the disease may be underestimated by X-rays. Magnetic Resonance Imaging has a role in making the diagnosis in the early stage (preosseous stage). The preosseous lesions usually have low signal intensity on T1-weighted images and high signal intensity on T2- weighted images [6]. Bone scintigraphy with 99mTc -MDP may show early ectopic ossification and may also contribute to the evaluation of the progression and the extent of the disease [7]. If the diagnosis of MOP is clear on clinical and radiological groundscalcified nodules biopsy should be avoided because it can result in recurrent ossification of the biopsy site [8]. Exacerbation of MOP may occur in spontaneously or be precipitated by trauma, Such As by surgical operationsor intramuscular injections; however they usually appear independently of extrinsic factors, with unpredictable frequency [2]. Differential diagnosis of MOP is obtained with dermatomyositis, tumoral idiopathic calcinosis, idiopathic calcinosis, and calcium metabolismdiseases, Osteosarcoma but in this case it is extremely painful with a high levels of alkaline phosphatase. Many treatments have been used, Corticosteroids, non-steroidal anti-inflammatory drugsbut without results. In vitro chemical studies have shown that bisphosphonates adsorb hydroxyapatite crystals, thus diminishing heterotopic bone formation during the active stage of the disease [9], when there is a severe limitation on movements and gastric intolerance, use of intravenous bisphosphonate may be indicated and may produce a good improvement. However, disease progression remains unchanged.

Myositis ossificansprogressive must diagnosed early and noninvasivel, based on history, clinical and radiological discovery. Early and correct diagnosis is fundamental for indication of proper management of the disease. Exacerbation of the diseasemay occur spontaneously or be precipitated by trauma, such as by surgical operationsorintramuscular injections.If the diagnosis of MOP is clear on clinical and radiological grounds the biopsy of calcified nodules should be avoided.

Les auteurs ne déclarent aucun conflit d'intérêts.

Tous les auteurs ont contribué à la rédaction de ce manuscrit et ont lu et approuvé la version finale.

Figure 1: clinical aspect of thigh

Figure 2: radiography of the right thigh showed a large calcifications or ectopic bone of soft tissues

1. Delatychi M, Rogers JG. The genetics of fibrodysplasia ossificans progressiva. ClinOrthopRel Res. 1998; 346: 15-18. PubMed | Google Scholar


2. Buyse G, Silberstein J, Goemans N, Casaer P. Fibrodysplasia ossificans progressiva: still turning into wood after 300 years? Eur J Pediatr. 1995; 154(9): 694-699. PubMed | Google Scholar


3. Rogers JG, GehoWB. Fibrodysplasia ossificans progressive: a survey of forty two cases. J Bone joint Surg. 1979; 61(6A): 909-14. PubMed | Google Scholar


4. Reinig JW, Hill SC, Fang M, Marini J, Zasloff MA. Fibrodyspla-siaOssificans Progressiva: CT Appearance. Radiology. 1986; 159(1): 153-7. PubMed | Google Scholar


5. Shafritz AB, Shore EM, Gannon FH. Overexpression of an osteogenicmorphogen in fibrodysplasia ossificans progressiva. N Engl J Med. 1996; 335(8): 555-561. PubMed | Google Scholar


6. Hiroaki H, Noriko A, Jiro M, Kazutoshi F, Shigeharu O, Gen N. Contrast-Enhanced MRI of an Early Preosseous Lesion of Fibrodysplasia Ossificans Progressiva in a 21-Month-Old Boy: Case report. AJR. October 2003; 181(4): 1145-1147. PubMed | Google Scholar


7. Elgazzar AH, Kriss VM, Gelfand MJ. Advanced fibrodysplasia ossificans progressiva. ClinNucl Med. 1995; 20(6): 519-521. PubMed | Google Scholar


8. Connor JM, Evans DA. Fibrodysplasia ossificans progressiva: the clinical features and natural history of 34 patients. J Bone Joint Surg. 1982; 64B(1):76-83. PubMed | Google Scholar


9. McEvoy GK. Unclassified therapeutic agents In: American Hospital Formulary Service (AHFS) Drug Information. Bethesda, Library of Congress. 2000; 3399-403. Google Scholar